TWO · 1780.TWO
Allied Biotech Corporation
NT$23.95-NT$0.10 (-0.42%)
Allied Biotech Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.01% below the high.
Loading market information…
TWO · 6543.TWO · TWD
Stock price, dividends
Quote as of Oct 30, 2026, 04:17 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Perfect Medical Industry Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.2% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Perfect Medical Industry Co., Ltd.’s forward annual dividend is NT$0.60 per share, paid quarterly. The forward yield is 3.49% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Perfect Medical Industry Co., Ltd. is a Taiwanese enterprise specializing in the manufacturing and global distribution of a diverse range of health and medical supplies. Their extensive product portfolio encompasses critical medical consumables, including specialized tubing and needle sets for procedures like hemodialysis and A.V. fistula, as well as various huber and winged needle sets, blood transfusion and safety infusion sets, safety extension sets, I.V. locks, disposable syringes, and medical face masks. These offerings are marketed under the 'PF' brand, reaching a broad international customer base across Asia, Africa, Europe, and South America. Established in 1989, the company maintains its headquarters in Changhua, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:52 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$23.95-NT$0.10 (-0.42%)
Allied Biotech Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.01% below the high.
NT$44.20+NT$1.35 (+3.15%)
BenQ Medical Technology Corporation’s quoted price sits in the upper half of its reported 52-week range, 11.42% below the high.
NT$72.10-NT$0.40 (-0.55%)
Crystalvue Medical Corporation’s quoted price sits in the lower half of its reported 52-week range, 13.45% below the high.
NT$28.50-NT$0.15 (-0.52%)
Chi Sheng Pharma & Biotech Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 7.92% below the high.
NT$16.90NT$0.00 (0.0%)
GenMont Biotech Incorporation’s quoted price sits in the lower half of its reported 52-week range, 14.43% below the high.
NT$17.60-NT$0.10 (-0.56%)
Arich Enterprise Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.67% below the high.
NT$21.20+NT$0.20 (+0.95%)
Bioptik Technology Incorporation’s quoted price sits in the lower half of its reported 52-week range, 24.29% below the high.
NT$32.15+NT$0.45 (+1.42%)
Lagis Enterprise Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.57% below the high.
